Tattoos have never been more mainstream. Around one in five Swedes has been tattooed, and for women under 40, that figure climbs above 40 percent. In Western countries broadly, roughly one in three adults now carries at least one tattoo. Most people made that choice with little to no information about what long-term science might eventually uncover — and that science is now starting to arrive.
A new epidemiological study from Lund University in Sweden suggests that tattoos could be a risk factor for melanoma — the most lethal form of skin cancer. The findings are not trivial, and they deserve to be understood clearly.
What the Lund University Study Found
Researchers identified 2,880 individuals diagnosed with cutaneous melanoma between the ages of 20 and 60, drawn from the Swedish National Cancer Register. For each case, they selected three age- and sex-matched controls from the general population.
On the surface, the tattooed rate looked almost identical across groups. Of those who had melanoma, 22% were tattooed, compared with 20% in the control group. But that gap widened significantly once researchers began accounting for variables.
After adjusting for sun exposure, skin type, income, education, marital status, and smoking, tattooed individuals faced a 29 percent increased relative risk of cutaneous melanoma compared to non-tattooed individuals. The ink itself, not the lifestyle around it, appears to be the signal.
When researchers excluded participants who were taking immunosuppressive medications, the risk rose further — to 32 percent — suggesting that immune function plays a meaningful role in how tattoo ink affects cancer risk.
Why Melanoma Matters
Melanoma is not the most common skin cancer, but it is the most dangerous. It spreads aggressively, it is difficult to detect in early stages, and it kills tens of thousands of people globally every year. A 29 percent elevated relative risk is not a footnote. It is a number that warrants real attention, particularly given how widespread tattooing has become.
The Biological Mechanism: What the Ink Actually Does
When tattoo ink is injected into the skin, the body perceives it as a foreign substance and the immune system activates. Ink pigments are encapsulated by immune cells, which hold them in place and transport them via lymphatic fluid to the lymph nodes.
This chronic immune activation may be part of the problem. Tattoo ink particles can deteriorate under UV illumination and migrate to lymph nodes, causing chronic inflammation and oxidative stress.
Azo pigments — the most common organic colorants in tattoo ink — are a particular concern, because they can break down into harmful chemicals that may cause cancer. This risk is amplified by exposure to UV radiation from the sun, sunbeds, or laser treatments, according to Emelie Rietz Liljedahl, associate researcher in toxicology at Lund University.
Red and yellow inks carry the highest documented risk from azo pigment breakdown products and have historically contained the most problematic heavy metals. Black inks made with carbon black may contain polycyclic aromatic hydrocarbons (PAHs).
The Timeline: When Is the Risk Highest?
The median time from first tattoo to cancer diagnosis was 8 years for lymphoma and 14 years for skin cancer. This suggests that potential harm develops gradually — not overnight — making long-term monitoring especially important for heavily tattooed individuals.
Part of a Larger Research Picture
The melanoma study does not exist in isolation. A first study from the same Lund University team, published in spring 2024, showed a possible link between tattoos and lymphoma. A second study found no association between tattoos and squamous cell carcinoma of the skin.
It is also worth noting that the science is not entirely settled. A study published in the December 2025 issue of the Journal of the National Cancer Institute found that people with three or more large tattoos had a 74 percent lower risk of melanoma than those who were tattoo-free — a finding that conflicts sharply with the Lund data and highlights how much remains unknown.
What This Doesn’t Mean
Having a tattoo does not mean you will get cancer. Risk is not destiny. The 29 percent figure is a relative risk at a population level, not a personal diagnosis.
However, further studies are needed before it is possible to talk about a causal link, emphasizes Christel Nielsen, one of the lead researchers. What the data does suggest is that the immune system is involved in ways that science is only beginning to map. Researchers are now exploring possible links between tattoo exposure and autoimmune conditions such as psoriasis and thyroid disease, in which the immune system is also implicated.
Practical Considerations
The tattoo ink market was relatively unregulated until 2022, when an addition to the EU’s chemical legislation introduced concentration limits for chemicals in tattoo ink. Despite this, market surveillance has shown that inks may still contain toxic chemicals exceeding the maximum limits.
Simpler designs using fewer colors and smaller surface areas reduce total ink load and overall chemical exposure. UV protection over tattooed skin — through SPF clothing or sunscreen — may reduce photochemical degradation of azo dyes.
And the FDA, for its part, has not been silent. In a December 2024 report on tattoo safety, the agency advised people to “think before you ink,” noting that it had received reports of infections from contaminated tattoo inks as well as allergic reactions.
The conversation about tattoos and long-term health is only beginning. For the millions who already have ink, awareness — not alarm — is the appropriate response. For those still deciding, the data now offers something that wasn’t available a generation ago: an informed starting point.
